MYCN and neuroblastoma: BET inhibitors, such as JQ1 and OTX015, can displace the BRD4 oncoprotein from chromatin (75), which potently represses MYCN transcription in neuroblastoma cell lines and effectively reduces neuroblastoma cell viability in vitro and in vivo (76, 77).